Frontida Biopharm

About:

Frontida Biopharm, Inc., an affiliate of Frontage Laboratories, Inc., is a Contract Development and Manufacturing Organization.

Website: http://frontidabiopharm.com/

Description:

Frontida Biopharm, Inc., an affiliate of Frontage Laboratories, Inc., is a Contract Development and Manufacturing Organization supporting biopharmaceutical companies in the scale-up and commercial manufacture of immediate and controlled release oral solid dose products. Frontida offers the capability to manufacture Highly Potent Active Ingredient (HPAI) products, Combination Products, as well as DEA schedules II – V products. Its patented Duragran® granulation process eliminates the need for traditional extrusion and compaction manufacturing steps, enhances drug loading, and creates better engineered and lower production-cost controlled release products.

Total Funding Amount:

$8.35M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Exton, Pennsylvania, United States

Founded Date:

2015-01-01

Contact Email:

info(AT)frontidabiopharm.com

Founders:

Song Li

Number of Employees:

101-250

Last Funding Date:

2016-08-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai